Over the past decade, India’s health tech sector has quietly evolved from a domestic story into a global phenomenon. And thanks to a unique blend of deep tech and healthcare expertise, it has grown into an industry that’s drawing attention from Europe to the U.S.

Foreign delegations are now touring Bengaluru’s innovation hubs, seeking AI-powered tools that save labour and streamline care. Panels at major summits are no longer just asking if India’s innovations can scale; they're debating how quickly they can reshape global healthcare.

The momentum isn’t accidental. It’s fueled by a blend of strong policy push, investor confidence, emerging bilateral partnerships, and India's outsized healthcare demands.

In this article, we explore what’s driving this shift, why the U.S. is turning to Indian startups for answers, and how homegrown innovation is redefining global healthcare from the ground up.

Why the U.S. Loves Indian Health Tech

The U.S is the world's most lucrative health tech market, with healthcare spending alone topping $4.8 trillion. And it is a clear opportunity for Indian startups to make a dent far beyond their home turf. The demand for scalable SaaS solutions, AI-driven platforms, and data unification tools has never been higher, and Indian firms are rapidly stepping in to fill the gaps.

Much of this boom can be traced back to shifts in U.S. policy. The implementation of the Affordable Care Act (Obamacare) and mandates around Electronic Health Records (EHR) created a pressing need for platforms that could streamline, analyse, and make sense of sprawling data.

That’s where Indian players like Innovaccer stepped in. The Noida-headquartered firm recently secured a $275 million Series F funding round to expand its Healthcare Intelligence Cloud and AI capabilities.

Innovaccer derives most of its revenue from the U.S. market, serving over 130 healthcare organizations and supporting tens of thousands of clinicians. Its platform has unified health data for millions of patients, helping providers reduce redundant tests and improve care coordination across fragmented systems.

Similarly, Wysa, an AI-powered mental health app, caters to over 10 million users globally and has forged partnerships with U.S. insurers and employers. Indegene, with its focus on pharma commercialisation, and Axtria, which serves over 100 life sciences companies, further showcase India’s deep domain expertise.

The driving force behind this is a powerful combination of cost advantage, tech talent, and Indian-origin founders who straddle both worlds.

The New Face of Indian Innovation

The new face of Indian health tech is defined not just by digital adoption, but by a surge of original, globally relevant innovation across the sector. India’s health tech market is projected to reach $21 billion by 2025, underpinned by over 10,000 startups, nearly half of which are based in tier 2 and tier 3 cities, reflecting the sector’s deep reach and diversity. 

This ecosystem is producing solutions that go far beyond basic telemedicine or digital records.

For example, Dozee, a Bengaluru-based startup, is pioneering AI-powered remote patient monitoring, while HealthifyMe leverages advanced analytics to deliver personalized wellness at scale.

Chennai-based Agilisium is another name in this shift. It has launched an AI lab to drive healthcare-specific GenAI models, aimed at solving data challenges in clinical research and life sciences.

Fueling this transformation is strong VC confidence. Venture capital and private equity investments have surged, exceeding $1 billion in just the first five months of 2024, a 220% increase year-over-year-signaling robust confidence in the sector’s global potential. Firms like Lightspeed and 2070Health are actively backing Indian startups operating in the India-U.S. corridor.

The Billion-Dollar Diagnosis

The global digital health market, projected to reach $549.7 billion by 2028, is evolving at breakneck speed, and Indian health tech startups are no longer just low-cost contenders but serious long-term players. 

This is fueled by rising healthcare expenditure, a growing burden of chronic diseases, and ambitious government initiatives like the National Digital Health Mission, which aims to build a unified digital health ecosystem.

Yet, innovation, not just affordability, is now the differentiator. Indian startups are pioneering AI-led diagnostics and data-driven platforms that address both domestic and global healthcare gaps.

For instance, India’s AI in the medical diagnostics market is projected to triple by 2030, as AI helps bridge the country’s acute shortage of skilled professionals. India has only one doctor for every 1,511 people, well below the WHO recommendation. AI-powered solutions are already reducing diagnostic turnaround times and expanding access, especially in underserved areas.

However, the path ahead is not without friction. India faces a significant talent crunch in AI and health informatics, with a projected shortfall of over one million skilled professionals by 2027. Geopolitical shifts and complex regulatory environments add further hurdles as Indian startups expand globally.

Still, with deepening investor confidence, robust policy backing, and a unique blend of tech and healthcare expertise, India’s health tech sector stands on the brink of a transformative decade, poised not just to respond to global healthcare challenges but to help redefine the future of care.

Edited by Harshajit Sarmah